200 related articles for article (PubMed ID: 17132710)
1. Effect of L-carnitine administration on erythropoietin use in thalassemic minor haemodialysis patients.
Di Iorio BR; Guastaferro P; Cillo N; Cucciniello E; Bellizzi V
Nephrol Dial Transplant; 2007 Mar; 22(3):954-5; author reply 955-6. PubMed ID: 17132710
[No Abstract] [Full Text] [Related]
2. Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients.
Arduini A; Bonomini M; Clutterbuck EJ; Laffan MA; Pusey CD
Nephrol Dial Transplant; 2006 Sep; 21(9):2671-2. PubMed ID: 16611680
[No Abstract] [Full Text] [Related]
3. L-carnitine supplementation in the dialysis population: are Australian patients missing out?
Reuter SE; Faull RJ; Evans AM
Nephrology (Carlton); 2008 Feb; 13(1):3-16. PubMed ID: 18199095
[TBL] [Abstract][Full Text] [Related]
4. Advances in carnitine in chronic uremia.
Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
[TBL] [Abstract][Full Text] [Related]
5. How can erythropoietin requirements be reduced in dialysis patients?
Kotanko P; Levin NW; Fishbane S; Tarng DC; Berns JS
Semin Dial; 2006; 19(5):363-72. PubMed ID: 16970733
[No Abstract] [Full Text] [Related]
6. Increase of plasma and red blood cell vitamin E concentration in uraemic patients on maintenance haemodialysis undergoing treatment with recombinant erythropoietin.
Paskalev D; Jankova T; Tschankova P; Steiner M; Nenov D
Nephrol Dial Transplant; 1993; 8(10):1187-8. PubMed ID: 8272244
[No Abstract] [Full Text] [Related]
7. Carnitine treatment improved quality-of-life measure in a sample of Midwestern hemodialysis patients.
Steiber AL; Davis AT; Spry L; Strong J; Buss ML; Ratkiewicz MM; Weatherspoon LJ
JPEN J Parenter Enteral Nutr; 2006; 30(1):10-5. PubMed ID: 16387893
[TBL] [Abstract][Full Text] [Related]
8. Drug treatment of hypertriglyceridaemia in chronic uraemic patients: preliminary report on D,L-carnitine and thiadenol.
Giorcelli G; Vacha G; Icardi GP
Proc Eur Dial Transplant Assoc; 1980; 17():367-71. PubMed ID: 7243794
[TBL] [Abstract][Full Text] [Related]
9. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
Reuter SE; Faull RJ; Ranieri E; Evans AM
Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
[TBL] [Abstract][Full Text] [Related]
10. [Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy].
Demelia L; Solinas A; Gogoni G; Marongiu F; Besson A
Recenti Prog Med; 1982 May; 72(5):664-74. PubMed ID: 6753066
[No Abstract] [Full Text] [Related]
11. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study.
Ciacci C; Peluso G; Iannoni E; Siniscalchi M; Iovino P; Rispo A; Tortora R; Bucci C; Zingone F; Margarucci S; Calvani M
Dig Liver Dis; 2007 Oct; 39(10):922-8. PubMed ID: 17693145
[TBL] [Abstract][Full Text] [Related]
12. Saving erythropoietin by administering L-carnitine?
Bommer J
Nephrol Dial Transplant; 1999 Dec; 14(12):2819-21. PubMed ID: 10570078
[No Abstract] [Full Text] [Related]
13. Interaction between alpha-interferon and erythropoietin in antiviral and antineoplastic therapy in uraemic patients on haemodialysis.
Nordio M; Guarda L; Lorenzi S; Lombini C; Marchini P; Mirandoli F
Nephrol Dial Transplant; 1993; 8(11):1308. PubMed ID: 8302480
[No Abstract] [Full Text] [Related]
14. Beneficial effect of recombinant human erythropoietin in beta thalassaemia patients on dialysis.
Cozma G; Cozma MC; Mattes U
Nephrol Dial Transplant; 1992; 7(1):82-3. PubMed ID: 1316587
[No Abstract] [Full Text] [Related]
15. [Initial observation on L-carnitine for asthenospermia with epididymal knob].
Shang X; Huang Y; Li K; Li W; Shi Y; Liu G; Hong J
Zhonghua Nan Ke Xue; 2004 Sep; 10(9):671-2, 675. PubMed ID: 15497707
[TBL] [Abstract][Full Text] [Related]
16. Newer aspects of carnitine metabolism in uremia.
Savica V; Calvani M; Benatti P; Santoro D; Monardo P; Mallamace A; Savica R; Bellinghieri G
Semin Nephrol; 2006 Jan; 26(1):52-5. PubMed ID: 16412827
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of clomiphene citrate and L-carnitine in idiopathic male infertility: a comparative study.
Moradi M; Moradi A; Alemi M; Ahmadnia H; Abdi H; Ahmadi A; Bazargan-Hejazi S
Urol J; 2010; 7(3):188-93. PubMed ID: 20845296
[TBL] [Abstract][Full Text] [Related]
19. Debate forum: carnitine supplements have not been demonstrated as effective in patients on long-term dialysis therapy.
Handelman GJ
Blood Purif; 2006; 24(1):140-2. PubMed ID: 16361854
[TBL] [Abstract][Full Text] [Related]
20. L-Carnitine effects on anemia in uremic rats treated with erythropoietin.
Azzadin A; Wollny T; Pawlak R; Malyszko JS; Malyszko J; Myśliwiec M; Buczko W
Nephron; 1999; 83(4):370-1. PubMed ID: 10575305
[No Abstract] [Full Text] [Related]
[Next] [New Search]
